Skip to content

Clinical trials

Lymphoma, B-Cell, Marginal Zone trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Country / region: Turkey (Türkiye) Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20141
20171
20214
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
BeOne Medicines2
AbbVie1
Cellectar Biosciences, Inc.1
Incyte Corporation1
Janssen Research & Development, LLC1
MEI Pharma, Inc.1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone12
Lymphoma, Follicular11
Leukemia, Lymphocytic, Chronic, B-Cell7
Lymphoma, Large B-Cell, Diffuse7
Lymphoma, Mantle-Cell7
Lymphoma, Non-Hodgkin7
Waldenstrom Macroglobulinemia7
Multiple Myeloma5
Blast Crisis4
Burkitt Lymphoma4

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.